Skip to content

To study the postoperative pain in patients of lower limb surgeries

To evaluate the postoperative analgesia of isobaric levobupivacaine alone compared with clonidine or nalbuphine under spinal anesthesia in patients of lower limb surgeries

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/08/027214
Enrollment
90
Registered
2020-08-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M849- Disorder of continuity of bone, unspecified

Interventions

Intervention1: Intrathecal drugs: groups will be compared with respect to onset and duration of sensory and motor blockade,duration of postoperative analgesia, sedation score, side effects and complic

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients undergoing lower limb surgeries 2. American Society of Anesthesiology (ASA) Grade I and II

Exclusion criteria

Exclusion criteria: 1.Neurological and musculoskeletal disease. 2.Patients with cardiovascular diseases. 3.Contraindications to regional anesthesia such as local infections/sepsis at the site of lumbar puncture, anatomical disorders of spine, shock, any bleeding disorder and patient on anticoagulants. 4.Hypersensitivity to study drugs 5.Pregnant women 6.History of opioid dependence

Design outcomes

Primary

MeasureTime frame
To evaluate the duration of postoperative analgesia of isobaric levobupivacaine alone compared with clonidine or nalbuphine under spinal anesthesia in patients of lower limb surgeries.Timepoint: pain will be assessed from 0 min till the 24 hours of the surgery

Secondary

MeasureTime frame
to evaluate the sedative and adverse effects of all the three drugs in the lower limb surgeriesTimepoint: effects will be assessed from 0 min till the 24 hours of the surgery

Countries

India

Contacts

Public ContactDr Balpreet Kaur

Sri Guru Ram Das Institute of Medical Sciences and Research

sgrdanaesthesia.academics@gmail.com9915530033

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026